Page 96 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 96

Page 3 of 3  Case Report


              Data availability statement                           4.  Cohen  H,  Williams  I,  Matthey  F,  Miller  RF,  Machin  SJ,  Weller  IV.  Reversible
                                                                      zidovudine-induced pure red-cell aplasia. AIDS. 1989;3(3):177–178. https://doi.
              Data sharing is not applicable to this article as no new data   org/10.1097/00002030-198903000-00009
              were created or analysed in this study.               5.  Majluf-Cruz A, Luna-Castanos G, Trevino-Perez S, Santoscoy M, Nieto-Cisneros L.
                                                                      Lamivudine-induced pure red cell aplasia. Am J Hematol. 2000;65(3):189–191.
                                                                      https://doi.org/10.1002/1096-8652(200011)65:3%3C189::AID-AJH2%3E3.
                                                                      0.CO;2-6
              Disclaimer                                            6.  John MA, Rhemtula YA, Menezes CN, Grobusch MP. Lamivudine-induced red cell
                                                                      aplasia.  J  Med  Microbiol.  2008;57(Pt  8):1032–1035.  https://doi.org/10.1099/
              The views expressed in the article are those of the authors   jmm.0.47782-0
              and not an official position of the institution or funder.  7.  Cohen K, Viljoen C, Njuguna C, Maartens G. Emtricitabine-associated red cell aplasia.
                                                                      AIDS. 2019;33(6):1095–1096. https://doi.org/10.1097/QAD.0000000000002136
                                                                    8.  Koduri PR. Novel cytomorphology of the giant proerythroblasts of parvovirus B19
              References                                              infection. Am J Hematol. 1998;58(2):95–99. https://doi.org/10.1002/(SICI)1096-
                                                                      8652(199806)58:2%3C95::AID-AJH1%3E3.0.CO;2-V
              1.  Council SANA. South African National AIDS Council (SANAC) Progress Report on   9.  Crabol Y, Terrier B, Rozenberg F, et al. Intravenous immunoglobulin therapy for
                the National Strategic Plan for HIV, TB and STIs (2013–2106). [cited 2017 Apr 05].   pure red cell aplasia related to human parvovirus b19 infection: a retrospective
                Available at: http://www.tbfacts.org/hiv-statistics-south-africa/#sthash.Unc3kNya.  study of 10 patients and review of the literature. Clin Infect Dis.2013;56(7):968–977.
                dpuf.                                                 https://doi.org/10.1093/cid/cis1046
              2.  Meidani  M,  Rezaei  F,  Maracy  MR,  Avijgan  M,  Tayeri  K.  Prevalence,  severity   10. Bulman J, Teo SY, Page E. An uncommon cause of anemia in pregnancy: A case
                and related factors of anemia in HIV/AIDS patients. J Res Med Sci. 2012;17(2):   report of emtricitabine-induced pure red cell aplasia (Abstract). In: 21st Annual
                138–142.                                              Conference of the British HIV Association (BHIVA). Brighton, UK: HIV Medicine;
              3.  Blanche P, Silberman B, Barreto L, Gombert B, Sicard D. Reversible zidovudine-  2015. p. 30.
                induced  pure  red  cell  aplasia.  AIDS.  1999;13(12):1586–1587.  https://doi.org/   11. Francois  KL,  Parboosing  R,  Moodley  P.  Parvovirus  B19  in  South  African  blood
                10.1097/00002030-199908200-00023                      donors. J Med Virol. 2019;91(7):1217–1223. https://doi.org/10.1002/jmv.25450






























































                                           http://www.sajhivmed.org.za  89  Open Access
   91   92   93   94   95   96   97   98   99   100   101